GMP Certification Awarded to Cryo-Save Lab, India

Zutphen, The Netherlands (ots/PRNewswire) -

Cryo-Save becomes the first stem cell bank operating in India to
receive the WHO-GMP certification

In a country where lack of stringent regulations has been causing
the general public to view stem cell banking with a certain degree of
trepidation, there is reason to cheer. Cryo-Save India, subsidiary of
the leading Europe-based family stem cell banking company, has become
the first to receive World Health Organisation - Good Manufacturing
Procedures (WHO-GMP) certification.

WHO-GMP certification guarantees superior quality, safety and
effectiveness of production. In the case of blood products like stem
cells, WHO-GMP guidelines govern every aspect of production and
testing which includes construction, design and maintenance of the
premises, qualification of equipment, extraction process, laboratory
conditions, component preparation and validation and cross
contamination, mix-ups and labelling, that can impact the quality of
the product.

Stem cell banking in India is still in its nascent stages with no
strict regulations governing the industry like in the west.
Organizations like Cryo-Save voluntarily opting for accreditations
and certifications help in elevating the credibility of the industry
in a market rift with scepticism and lack of knowledge on the merits
of an evolving technology.

Commenting on the certification, Arnoud van Tulder, CEO,
Cryo-Save Group said, "As a Group, we are thrilled to receive the
WHO-GMP certification in India. In the absence of a guidance
mechanism, new parents are constantly battling questions on quality
and methods employed by stem cell banks in India. I am certain that
the certification will serve the cause of boosting the confidence
levels in the stem cell industry and our Company in particular."

Marc Waeterschoot, QP and Co-founder, Cryo-Save Group said,
"Given that the concept of stem cell banking and therapy is
relatively new in India, we are happy to have proactively obtained
WHO-GMP certification since quality and dependability of stem cell
banks is a huge concern in emerging markets."

More information:

Cryo-Save: http://www.cryo-save.com/group

Cryo-Save, the leading international family stem cell bank,
already stores more than 185,000 samples from cord blood and
umbilical cord tissue for newborns and adipose tissue for adults.
These stem cells can mean the difference between life and death in
the case of future threats to the health of the donors. There are
already several diseases that can be cured by the use of stem cells,
and the number of treatments will only increase. The use of stem
cells from adipose tissue is increasingly popular in plastic surgery.
Driven by its international business strategy, Cryo-Save is now
represented in over 40 countries on four continents, with
ultra-modern processing and storage facilities in the United States,
Belgium, Germany, Dubai, India, South Africa and France (validation
in progress).

ots Originaltext: Cryo-Save AG
Im Internet recherchierbar: http://www.presseportal.de

Contact:
Contacts: Cryo-Save Marketing and Communications Department: Tel:
+41-55-222-0251, Renzo Gentile , renzo.gentile@cryo-save.com ; Ashley
Ringger, ashley.ringger@cryo-save.com